Skip to main content
Fig. 7 | Clinical Epigenetics

Fig. 7

From: KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations

Fig. 7

KDM4C served as a potential biomarker in gastric cancer. A, The expression of KDM4C in the digestive system cancer cohort of TCGA. B Four paired tissues from patients with gastric cancer were lysed, followed by immunoblotting analysis. C The RNA expression of KDM4C in the gastric cancer cohort of TCGA. D Kaplan–Meier plots analysis of OS in TP53-mutated gastric cancer patients with high or low KDM4C mRNA levels. E Kaplan–Meier plots analysis of OS, FP, and PPS in patients with gastric cancer with high or low KDM4C mRNA levels

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us